or Try an Advanced Search...

    Vision Stocks List

    Symbol Grade Name % Change
    OCUP F Ocuphire Pharma, Inc. 0.29
    EYE F National Vision Holdings, Inc. 0.00
    BLCO F Bausch + Lomb Corporation 1.67
    STAA D STAAR Surgical Company -1.21
    COO C Cooper Companies, Inc. (The) 0.00
    SGHT C Sight Sciences, Inc 4.68
    RXST C RxSight, Inc. -3.16
    OCGN C Ocugen, Inc. 1.02
    GKOS B Glaukos Corporation -0.88
    WRBY B Warby Parker Inc. 2.67
    View As Page of Charts
    Related Industries: Biotechnology Electronic Components Long-Term Care Facilities Medical Devices Medical Instruments & Supplies Specialty Retail
    Related Stock Lists: Ophthalmology Eye Eyewear Glaucoma Optometry Blindness Cataract Surgery Cataracts Contact Lenses Corrective Lenses Eye Surgery Treatment Of Glaucoma Aspheric Lens Astigmatism Contact Lens Diabetic Retinopathy Eye Care Eye Diseases Intraocular Pressure Lenses

    Related ETFs - A few ETFs which own one or more of the above listed Vision stocks.

    Symbol Grade Name Weight
    PSCH B PowerShares S&P SmallCap Health Care Portfolio 6.19
    XHE C SPDR S&P Health Care Equipment 5.77
    AWEG B Alger Weatherbie Enduring Growth ETF 3.77
    NBCC B Neuberger Berman Next Generation Connected Consumer ETF 3.33
    XRT B SPDR S&P Retail ETF 2.32
    View all Vision ETFs...
    Compare ETFs
    Compare AWEG to NBCC Compare AWEG to XRT Compare PSCH to NBCC

        Vision Stocks Recent News

        Date Stock Title
        May 16 OCGN Nayax Posts Weak Q1 Results, Joins GameStop, Iris Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
        May 15 COO CooperCompanies to Participate in the Jefferies Global Healthcare Conference
        May 15 COO Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
        May 15 OCGN Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
        May 15 OCGN Ocugen Inc (OCGN) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...
        May 15 OCGN Q1 2024 Ocugen Inc Earnings Call
        May 14 COO CooperCompanies to Participate in the William Blair Growth Stock Conference
        May 14 OCGN Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript
        May 14 GKOS Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
        May 14 OCGN Ocugen GAAP EPS of -$0.05 beats by $0.01, revenue of $1.01M
        May 14 OCGN Ocugen Provides Business Update with First Quarter 2024 Financial Results
        May 14 COO Reasons to Add The Cooper Companies (COO) to Your Portfolio
        May 13 WRBY Three Growth Companies With High Insider Ownership And A Minimum 25% Earnings Increase
        May 13 RXST RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
        May 13 OCGN Ocugen Q1 2024 Earnings Preview
        May 13 STAA Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock
        May 12 OCUP Ocuphire Pharma First Quarter 2024 Earnings: Misses Expectations
        May 10 OCGN Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
        May 10 WRBY Warby Parker Inc. (NYSE:WRBY) Q1 2024 Earnings Call Transcript
        May 10 WRBY Warby Parker Guidance Achievable, Path Still Uncertain, Morgan Stanley Says
        Related Industries: Biotechnology Electronic Components Long-Term Care Facilities Medical Devices Medical Instruments & Supplies Specialty Retail
        Related Stock Lists: Ophthalmology Eye Eyewear Glaucoma Optometry Blindness Cataract Surgery Cataracts Contact Lenses Corrective Lenses Eye Surgery Treatment Of Glaucoma Aspheric Lens Astigmatism Contact Lens Diabetic Retinopathy Eye Care Eye Diseases Intraocular Pressure Lenses
        Vision

        Browse All Tags